|
(P414) |
Human myocardial extracellular matrix coating improves biocompatibility of biologic and polymeric tissue engineering scaffolds |
|
|
M. Becker, M. Schneider, W. T. Tung, V. Falk, N. Ma, M. Seifert, C. Stamm (Berlin, Teltow) |
|
(P415) |
microRNA-17-92 in acute cardiac allograft rejection in experimental heart transplantation |
|
|
M. Adam, S. Günther, X. Hu, G. Tediashvili, D. Wang, J. Velden, T. Renné, T. Deuse, H. Reichenspurner, S. Baldus, P. S. Tsao, S. Schrepfer (Köln, Hamburg; San Francisco, Palo Alto, US) |
|
(P416) |
Endothelial PGC-1 α is required to maintain the vascular protective effects of exercise training |
|
|
T. Jansen, S. Kröller-Schön, E. Schulz, T. Münzel (Mainz) |
|
(P417) |
Reprogramming of epicardial derived cells into functional cardiomyocytes by the cardiac microenvironment |
|
|
A. Marzoq, Z. Ding, O. Sergeeva, D. Friebe, J. Höll, X. Ke, A. Borkhardt, J. Schrader (Düsseldorf, Hannover) |
|
(P418) |
EPO prevents increased adipocyte formation in STAT3-knockout hearts |
|
|
E. Stelling, M. Ricke-Hoch, B. Stapel, S. Erschow, D. Hilfiker-Kleiner (Hannover) |
|
(P419) |
Detection of acute changes in left ventricular function by myocardial deformation analysis after excessive alcohol ingestion |
|
|
M.-M. Becker, J. Schröder, S. Hamada-Langer, E. Altiok, M. Hein, M. Almalla, A. Napp, N. Marx (Aachen) |